Taken together, our data indicate that reduced osteoprotegerin expression is involved in the development, progression, and metastasis of colorectal carcinoma, suggesting that osteoprotegerin functions as a tumor suppressor in colorectal carcinoma. This evidence concerns the gene TNFRSF11B and colorectal carcinoma.